| Primary |
| Hypertension |
26.5% |
| Coronary Artery Disease |
17.4% |
| Atrial Fibrillation |
14.4% |
| Arrhythmia |
5.3% |
| Cardiac Failure |
5.3% |
| Essential Hypertension |
4.5% |
| Osteoarthritis |
3.8% |
| Acute Coronary Syndrome |
3.0% |
| Anaesthesia |
2.3% |
| Angina Pectoris |
2.3% |
| Tachycardia |
2.3% |
| Ventricular Tachycardia |
2.3% |
| Arteriosclerosis |
1.5% |
| Cardiac Disorder |
1.5% |
| Extrasystoles |
1.5% |
| Glaucoma |
1.5% |
| Intentional Overdose |
1.5% |
| Ischaemic Cerebral Infarction |
1.5% |
| Aortic Valve Replacement |
0.8% |
| Cardiac Hypertrophy |
0.8% |
|
| Vomiting |
13.5% |
| Tachycardia |
10.8% |
| Atrioventricular Block |
8.1% |
| Atrial Fibrillation |
5.4% |
| Death |
5.4% |
| Heart Rate Decreased |
5.4% |
| Hypertension |
5.4% |
| Overdose |
5.4% |
| Sinus Bradycardia |
5.4% |
| Sudden Death |
5.4% |
| Syncope |
5.4% |
| Acute Myocardial Infarction |
2.7% |
| Angioedema |
2.7% |
| Arteriospasm Coronary |
2.7% |
| Asphyxia |
2.7% |
| Asthma |
2.7% |
| Bronchial Obstruction |
2.7% |
| Cardio-respiratory Arrest |
2.7% |
| Cardiogenic Shock |
2.7% |
| Depression |
2.7% |
|
| Secondary |
| Hypertension |
28.0% |
| Atrial Fibrillation |
20.4% |
| Arrhythmia |
15.6% |
| Coronary Artery Disease |
14.4% |
| Essential Hypertension |
6.0% |
| Acute Myocardial Infarction |
2.8% |
| Cardiac Failure |
2.8% |
| Tachycardia |
2.8% |
| Cardiac Disorder |
1.2% |
| Acute Coronary Syndrome |
0.8% |
| Arteriosclerosis |
0.8% |
| Extrasystoles |
0.8% |
| Ischaemic Cerebral Infarction |
0.8% |
| Aortic Valve Replacement |
0.4% |
| Cardiac Hypertrophy |
0.4% |
| Cardiomyopathy |
0.4% |
| Chest Discomfort |
0.4% |
| Diuretic Therapy |
0.4% |
| Heart Rate |
0.4% |
| Heart Rate Increased |
0.4% |
|
| Ventricular Tachycardia |
23.9% |
| Tachycardia |
17.4% |
| Heart Rate Decreased |
6.5% |
| Hypertension |
6.5% |
| Renal Artery Thrombosis |
6.5% |
| Atrial Fibrillation |
4.3% |
| Pleural Effusion |
4.3% |
| Pyrexia |
4.3% |
| Asphyxia |
2.2% |
| Asthma |
2.2% |
| Bradycardia |
2.2% |
| Bronchial Obstruction |
2.2% |
| Condition Aggravated |
2.2% |
| Death |
2.2% |
| Depression |
2.2% |
| Ischaemic Cerebral Infarction |
2.2% |
| Myocardial Ischaemia |
2.2% |
| Shock |
2.2% |
| Syncope |
2.2% |
| Viith Nerve Paralysis |
2.2% |
|
| Concomitant |
| Hypertension |
29.0% |
| Myocardial Ischaemia |
10.9% |
| Non-small Cell Lung Cancer |
10.5% |
| Prophylaxis |
7.1% |
| Ill-defined Disorder |
5.0% |
| Diabetes Mellitus |
4.5% |
| Rheumatoid Arthritis |
4.3% |
| Infusion |
3.3% |
| Product Used For Unknown Indication |
3.3% |
| Gastritis |
2.9% |
| Acute Coronary Syndrome |
2.6% |
| Arteriosclerosis |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Dehydration |
1.9% |
| Depression |
1.9% |
| Pain |
1.9% |
| Thrombosis Prophylaxis |
1.9% |
| Arrhythmia |
1.4% |
| Atrial Fibrillation |
1.4% |
| Hypertonia |
1.4% |
|
| Thrombocytopenia |
16.9% |
| Respiratory Distress |
8.5% |
| Vertigo |
6.8% |
| Hypophosphataemia |
5.1% |
| Leukopenia |
5.1% |
| Muscle Spasms |
5.1% |
| Myocardial Ischaemia |
5.1% |
| Transaminases Increased |
5.1% |
| Vomiting |
5.1% |
| Acute Myocardial Infarction |
3.4% |
| Acute Respiratory Failure |
3.4% |
| Anaemia |
3.4% |
| Cerebrovascular Accident |
3.4% |
| Dyspnoea Exertional |
3.4% |
| Menorrhagia |
3.4% |
| Myocardial Infarction |
3.4% |
| Oedema |
3.4% |
| Pyelonephritis |
3.4% |
| Renal Failure |
3.4% |
| Spinal Fracture |
3.4% |
|
| Interacting |
| Glaucoma |
40.0% |
| Arrhythmia |
20.0% |
| Atrial Fibrillation |
20.0% |
| Hyperthyroidism |
20.0% |
|
|
